Revista Clínica Escuela de Medicina UCR-HSJD, Volumen 3, Número 4

URI permanente para esta colección

Examinar

Envíos recientes

Mostrando 1 - 4 de 4
  • Ítem
    Linfoma de parótida
    (2012-06-01 00:00:00) Morera Hidalgo, Herman
  • Ítem
    Enfermedad de Peyronie
    (2012-06-01 00:00:00) Ramírez Salas, Guido; Fiedler Velásquez, Eduardo
    Francoise Gigot de la Peyronie first described Peyronie’s disease in 1753. It generally appears on the 4th to the 6th decades of life as an acquired inflammatory disorder, characterized by the appearance of fibrous plaques in the Tunica Albuginea of the penis that causes pain, abnor- mal curvature, deformity, shortening, and in some cases, erectile dysfunction. In advanced cases, sexual activity is impeded. The objective of this review is to present new concepts and advances in treatments, including surgical, non surgical, oral or intralesional, in order to provide an adequate management of the patient, achieve improvement of symptomatology and enhance the quality of life for patients suffering from this disorder
  • Ítem
    Femenina 39 años con Heterotopia Pancreática
    (2012-06-01 00:00:00) Portuguez Barboza, Rafael; Zúñiga Monge, Daniel; Barboza Solís, Amalia; Vargas Baldares, Ruy
    Pancreatic heterotopia (HP) is an asymptomatic malformation that can occur anywhere in the gastrointestinal tract. Occasionally symptoms can occur depending on the location of the le- sion. Surgical treatment is recommended in symptomatic patients or if malignancy is present. Benign asymptomatic lesions are managed con- servatively.
  • Ítem
    Tumor de klatskin
    (2012-06-01 00:00:00) Granados Quesada, Ronny; Vargas Carranza, Julia
    Hilar cholangiocarcinomas are rare neoplasms. Due to their anatomical location, complete surgical resection is technically difficult. It has an annual incidence of 1 in 100.000 habitants. Surgery could be the definitive in early stages, with a 5-years survival of 20%. The majority of pa- tients has advanced disease at diagnoses, with an average survival of 6 to 7 months and usually requires palliative treatment only. Longterm survival is only achieved in patients who have undergone complete resection. Consequently, identification of patients with risk factors, early diagnosis and evaluation of respectability by a surgeon with experience in hepatobiliary surgery are essential